Endo Pharmaceuticals (NASDAQ:ENDP) faces a drug shortage risk for some of its opiates, such as Percocet, as Novartis Consumer Group sorts out a mix-up that could cause extended release opiates for Endo Pharmaceuticals to be bottled together with over-the-counter pain reliever Excedrin and stimulant NoDoz. The factory shutdown, though temporary, could cause a shortage for […]
Pfizer‘s (NYSE:PFE) Icagen (NASDAQ:ICGN) acquisition has yet to close, but the talent exodus from the drug development company is already under way. Mark Suto, Icagen’s vice president of chemical and pharmaceutical science, is leaving the Durham, North Carolina-based company for the Southern Research Institute. Suto has been named vice president of the drug discovery division […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.